Human EGFRvIII-coupled Magnetic Beads

ユーザーレビュー
製品番号/仕様
価格
数量
MBS-K020-2mg
$1070.00
MBS-K020-10mg (5mg X 2)
$3350.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Items
    Size 2mg
    Size 10mg (5mg × 2)
    Particle size
    2 μm
    2 μm
    Physical appearance
    Powder mixture
    Powder mixture
    Binding Capacity
    >200 pmol (30 μg) antibody/mg beads
    >200 pmol (30 μg) antibody/mg beads
    Formulation
    PBS, pH7.4, with 10% Trehalose
    PBS, pH7.4, with 10% Trehalose
    Reconstitution
    2 mL sterile deionized water (1 mg beads/mL)
    5 mL sterile deionized water (1 mg beads/mL)
  • Product Description

    The Human EGFRvIII-coupled Magnetic Beads is produced by coupling biotinylated EGFRvIII protein to streptavidin-conjugated magnetic beads. Because Streptavidin (SA) has an extraordinarily high affinity for biotin with a dissociation constant (Kd) on the order of 10-14 mol/L, the biotinylated protein can bind to the SA beads irreversibly. The pre-coupled beads are ready to use for capturing anti-EGFRvIII antibody from your sample with high specificity.

  • Application

    This product is intended for immunocapture, biopanning. This is a non-sterile product.

    * The Isotype control (Cat. No. SMB-B01) is sold separately.

  • Reconstitution

    See Certificate of Analysis (CoA) for detailed instruction.

  • Storage

    Upon receipt, please store the beads at -20°C. The shelf life is 6 months at -20 °C.

    Please avoid more than 3 freeze-thaw cycles once reconstitution, immediate use after reconstitution is highly recommended.

  • Assay Principles

    Antibody Purification:
    1. Resuspend the lyophilized beads by adding the buffer of choice.
    2. Add analyte to the suspension, mix and incubate to enable specific binding of the beads and the target protein.
    3. Magnetize beads, remove supernatant, and wash unbound protein fractions to capture target protein-bound beads.
    4. Wash, magnetize the beads and collect purified target protein for use in downstream applications.

    The magnetic beads technology makes use of the easy and efficient collection of beads in magnetic field to facilitate antibody purification in a simple workflow of “bind-wash-elute”. In contrast to common separation techniques, this method does not require columns or centrifugation, and is therefore ideal in high-throughput applications.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • Typical Data

     EGFRvIII TYPICAL DATA

    Immobilized 44 μg EGFRvIII protein/1 mg beads can bind Anti-EGFR Antibody (Cetuximab) with an EC50 of 0.7172 μg/mL.

    Protocol
  •  EGFRvIII TYPICAL DATA

    Immobilized 44 μg EGFRvIII protein/1mg beads can bind Anti-EGFRvIII Antibody with an EC50 of 0.8856 μg/mL (Routinely tested).

    Protocol

ユーザーレビュー
コメントを投稿

最新の進展

 
医薬品開発の進捗
  • 英語名:

    Epidermal growth factor receptor variant III

  • カテゴリ:

  • 市販の医薬品数:

    0 詳細

  • 治験医薬品数:

    14 詳細

  • 最新の開発ステージ:

    Phase 2 Clinical

お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8